Effect of bevacizumab in first-line chemotherapy on progression-free survival in advanced ovarian clear cell carcinoma.

Shinichi Tate,Kyoko Nishikimi,Ayumu Matsuoka,Makio Shozu

Effect of bevacizumab in first-line chemotherapy on progression-free survival in advanced ovarian clear cell carcinoma.

2020

Shinichi Tate
Kyoko Nishikimi
Ayumu Matsuoka
Makio Shozu

e18086Background: Advanced ovarian clear cell carcinoma (ACCC, stage III/IV disease) is a rare tumor characterized by chemoresistance. To evaluate the efficacy of bevacizumab (Bev) for ACCC, we inv...

Keywords:

Bevacizumab
Oncology
Progression-free survival
Internal medicine
first line chemotherapy
Medicine
Clear cell carcinoma
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations